www.linkedin.com/pulse/fda-gr...
FDA Grants RMAT Designation to Mesoblast’s Revascor® for Severe Heart Disease in Children
kstrategyand.com/pharma-news
#Revascor #rexlemestrocelL #FDAApproval #RMATDesignation #ClinicalTrials #StemCellTherapy #Humanteconomy #Humantech #KStrategyand
0
0
0
0